Successfully reported this slideshow.
Your SlideShare is downloading. ×

CARRE Risk Factor Reference Repository

Ad

CARRE
Personalized patient empowerment and shared decision
support for cardiorenal disease and comorbidities
Risk Factor R...

Ad

FP7 – ICT - 614440 http://www.carre-project.eu
CARRE
Cardiorenal
comorbidity management
via empowerment and
shared informe...

Ad

FP7 – ICT - 614440 http://www.carre-project.eu
motivation
 significant increase in the prevalence and incidence
of chroni...

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Loading in …3
×

Check these out next

1 of 29 Ad
1 of 29 Ad

More Related Content

Similar to CARRE Risk Factor Reference Repository (20)

More from CARRE project (14)

CARRE Risk Factor Reference Repository

  1. 1. CARRE Personalized patient empowerment and shared decision support for cardiorenal disease and comorbidities Risk Factor Repository Evaluation September 2016
  2. 2. FP7 – ICT - 614440 http://www.carre-project.eu CARRE Cardiorenal comorbidity management via empowerment and shared informed decision FP7-ICT-2013-611140 consortium: 6 partners from 4 EU countries coordinator: Eleni Kaldoudi (DUTH) duration: Nov 2013 – Oct 2016 budget: 3,210,470€ http://carre-project.eu/ Democritus Univ. of Thrace DUTH, GR The Open University, UK Univ. of Bedfordshire, UK Vilnius Univ. Hospital, LT Kaunas Univ., LT Industrial Research Institute for Automation & Measurements, PL
  3. 3. FP7 – ICT - 614440 http://www.carre-project.eu motivation  significant increase in the prevalence and incidence of chronic disease  ½ of all chronic patients present comorbidities  the chronic patient is mostly an outpatient  needs to care for herself at home  mainly away from continuous professional care  while trying to lead a normal life prevent detect manage
  4. 4. FP7 – ICT - 614440 http://www.carre-project.eu medical domain chronic cardiorenal disease and comorbidities  simultaneous (causal) dysfunction of kidney and heart  diabetes and/or hypertension common underlying causes  a number of other serious comorbidities often present nephrogenic anemia, renal osteodystrophy, malnutrition, blindness, neuropathy, severe atherosclerosis, cardiovascular episodes, and eventually end-stage renal disease and/or heart failure, and death  deterioration to end stage renal/heart disease is life threatening, irreversible and expensive to manage
  5. 5. FP7 – ICT - 614440 http://www.carre-project.eu cardiorenal disease & comorbidities some numbers…  hypertension  1/3 of adults (US 2008)  diabetes  8% of overall population  chronic kidney disease  9-16% of overall population  44% of chronic kidney disease is due to diabetes  86% of chronic kidney disease has at least 1 comorbidity  most patients with chronic kidney disease develop cardiovascular disease  chronic heart failure  1-2% of total healthcare costs  end-stage renal disease (dialysis)  >2% of total healthcare costs
  6. 6. FP7 – ICT - 614440 http://www.carre-project.eu CARRE approach foster understanding of comorbid condition calculate informed comorbidity progression compile personalized empowerment services support shared informed decision and integrated management
  7. 7. FP7 – ICT - 614440 http://www.carre-project.eu medical evidence aggregation evidence based medical literature Educational resources … social media personal health information quantified self weight physical activity blood pressure glucose CARRE approach private public data harvesting & interlinking LOD comorbidity model visualization (generic and personalized) patient empowerment & decision support services
  8. 8. FP7 – ICT - 614440 http://www.carre-project.eu modelling health risk factors disorder 1 (as a risk factor) disorder 2 (as a probable consequence) leads to under certain conditions with a probability x E. Kaldoudi, et al. CARRE D.2.1, 2014 risk factors are reported in medical literature (top level evidence: systematic reviews with meta-analysis)
  9. 9. characterizes is a value of type of risk element biomedical ratio value confidence intervalratio type adjustment for modelling health risk factors E. Kaldoudi, et al. CARRE D.2.2, 2014 risk element observable observable condition satisfies observable condition 1…N determines risk evidence 1…N has risk ratio risk ratio evidence source has evidence source source risk element target risk element causes, is an issue in, … risk evidence demographic genetic behavioural intervention environmental is a value of 1…N measures the state of risk element condition disorder A. Third, E. Kaldoudi, G. Gotsis, S. Roumeliotis, K. Pafili, J. Domingue, Capturing Scientific Knowledge on Medical Risk Factors, K-CAP2015, ACM, NY, USA, Oct. 7-10, 2015
  10. 10. risk factor identification methodology search ground knowledge to identify major risk factors (guidelines and their literature: KDIGO, KDOQI, ACC/AHA, NICE, ESC, EASD, ADA) if result found include all risk evidences from the most recent yes search PubMed: condition A AND condition B (limited to systematic reviews with metaanalyses identify major risk factors (keywords) search PubMed: condition A AND condition B noif result found include relevant risk evidence from latest and highest level yes search again for next update (1 year) no E. Kaldoudi, et al. CARRE D.2.2, 2014
  11. 11. FP7 – ICT - 614440 http://www.carre-project.eu some of the major related conditions 1. Acute kidney injury 2. Acute myocardial infarction 3. Age 4. Albuminuria 5. Anaemia 6. Angina pectoris 7. Asthma 8. Atrial fibrillation 9. Chronic kidney disease 10. Chronic obstructive pulmonary disease 11. Cholelithiasis 12. Colorectal Cancer 13. Coronary and carotid revascularisation 14. Death 15. Depression 16. Diabetes 17. Diabetic nephropathy 18. Drugs 19. Dyslipidemia 20. Family history 21. Heart Failure 22. Hyperkalemia 23. Hypertension 24. Hyperuricemia 25. Hypoglycaemia 26. Ischemic heart disease 27. Ischemic stroke 28. Left ventricular hypertrophy 29. Obesity 30. Obstructive Sleep Apnoea 31. Myocardial infarction 32. Osteoarthritis 33. Pancreatic Cancer 34. Peripheral Arterial Disease 35. Physical activity 36. Smoking 37. …
  12. 12. FP7 – ICT - 614440 http://www.carre-project.eu obesity diabetescauses when 23BMI34 risk ratio = 1.61 obesity hypertensioncauses when 99.4  Waist Circumference  106.2 AND sex=male risk ratio = 2.50 obesity heart failurecauses when 25  BMI  30 AND sex=female risk ratio = 2.50
  13. 13. FP7 – ICT - 614440 http://www.carre-project.eu hypertension chronic renal diseasecauses when systolic BB  140mmHg AND/OR diastolic BB  90 mmHg risk ratio = 2.00 smoking chronic renal disease is an issue in when smoking status = current AND sex=male risk ratio = 2.40 so far… 253 major risk associations (or evidences) identified in medical literature (which involve 53 health conditions and 82 related observables) as included in the CARRE risk factor database and predictive model
  14. 14. FP7 – ICT - 614440 http://www.carre-project.eu risk factor reference repository https://entry.duth.carre-project.eu/
  15. 15. FP7 – ICT - 614440 http://www.carre-project.eu https://entry.duth.carre-project.eu/
  16. 16. FP7 – ICT - 614440 http://www.carre-project.eu risk factors
  17. 17. FP7 – ICT - 614440 http://www.carre-project.eu risk factors
  18. 18. FP7 – ICT - 614440 http://www.carre-project.eu risk evidences
  19. 19. FP7 – ICT - 614440 http://www.carre-project.eu risk factor reference repository
  20. 20. FP7 – ICT - 614440 http://www.carre-project.eu risk factor reference repository
  21. 21. FP7 – ICT - 614440 http://www.carre-project.eu risk factor reference repository
  22. 22. FP7 – ICT - 614440 http://www.carre-project.eu risk factor reference repository
  23. 23. FP7 – ICT - 614440 http://www.carre-project.eu risk elements
  24. 24. FP7 – ICT - 614440 http://www.carre-project.eu observables
  25. 25. FP7 – ICT - 614440 http://www.carre-project.eu experts
  26. 26. FP7 – ICT - 614440 http://www.carre-project.eu experts
  27. 27. FP7 – ICT - 614440 http://www.carre-project.eu evaluation scenarios and procedure  explore the system  login  dashboard – browse and evaluate  explore – visual exploration of the data  study risk evidence – navigate and study risk evidences  edit data – edit data and insert new evidence  answer the evaluation survey  discuss your comments and suggestions
  28. 28. acknowledgment work funded under project CARRE co-funded by the European Commission under the Information and Communication Technologies (ICT) 7th Framework Programme Contract No. FP7-ICT-2013-611140 CARRE: Personalized patient empowerment and shared decision support for cardiorenal disease and comorbidities http://www.carre-project.eu/
  29. 29. Contact Eleni Kaldoudi Associate Professor School of Medicine Democritus University of Thrace Alexandroupoli, Greece Tel: +302551030329 Tel: +30 6937124358 Email: kaldoudi@med.duth.gr Email: carre@med.duth.gr http://www.carre-project.eu

×